Skip to main content

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

Publication ,  Conference
Erba, HP; O'Donnell, M; Allen, SL; Baer, MR; Powell, BL; Stone, RM; Bennett, JM; Lundberg, AS; Capizzi, RL; Rizzieri, DA
Published in: Blood
November 20, 2009

Abstract 1047Poster Board I-69

Duke Scholars

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

1047 / 1047

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Erba, H. P., O’Donnell, M., Allen, S. L., Baer, M. R., Powell, B. L., Stone, R. M., … Rizzieri, D. A. (2009). Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. In Blood (Vol. 114, pp. 1047–1047). American Society of Hematology. https://doi.org/10.1182/blood.v114.22.1047.1047
Erba, Harry P., Margaret O’Donnell, Steven L. Allen, Maria R. Baer, Bayard L. Powell, Richard M. Stone, John M. Bennett, Ante S. Lundberg, Robert L. Capizzi, and David A. Rizzieri. “Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.” In Blood, 114:1047–1047. American Society of Hematology, 2009. https://doi.org/10.1182/blood.v114.22.1047.1047.
Erba HP, O’Donnell M, Allen SL, Baer MR, Powell BL, Stone RM, et al. Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. In: Blood. American Society of Hematology; 2009. p. 1047–1047.
Erba, Harry P., et al. “Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.Blood, vol. 114, no. 22, American Society of Hematology, 2009, pp. 1047–1047. Crossref, doi:10.1182/blood.v114.22.1047.1047.
Erba HP, O’Donnell M, Allen SL, Baer MR, Powell BL, Stone RM, Bennett JM, Lundberg AS, Capizzi RL, Rizzieri DA. Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study. Blood. American Society of Hematology; 2009. p. 1047–1047.

Published In

Blood

DOI

EISSN

1528-0020

ISSN

0006-4971

Publication Date

November 20, 2009

Volume

114

Issue

22

Start / End Page

1047 / 1047

Publisher

American Society of Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology